Can screening for atrial fibrillation be implemented at scale?

Nicole Lowres^{1

2}, Lis Neubeck³, Saul B Freedman^{2

4

5

6}

Affiliations

¹ Nursing School, Charles Perkins Centre, University of Sydney, Level 2, Building D17, Sydney, Australia nicole.lowres@sydney.edu.au.
² Vascular Biology, Anzac Research Institute, Sydney, Australia.
³ Nursing School, Charles Perkins Centre, University of Sydney, Level 2, Building D17, Sydney, Australia.
⁴ Sydney Medical School, University of Sydney, Sydney, Australia.
⁵ Cardiology Department, Concord Repatriation General Hospital, Sydney, Australia.
⁶ Heart Research Institute, Charles Perkins Centre, University of Sydney, Sydney Australia.

Editorial

Nicole Lowres et al. Europace. 2016 Oct.

. 2016 Oct;18(10):1449-1451.

doi: 10.1093/europace/euw030. Epub 2016 Mar 3.

Nicole Lowres^{1

2}, Lis Neubeck³, Saul B Freedman^{2

4

5

6}

¹ Nursing School, Charles Perkins Centre, University of Sydney, Level 2, Building D17, Sydney, Australia nicole.lowres@sydney.edu.au.
² Vascular Biology, Anzac Research Institute, Sydney, Australia.
³ Nursing School, Charles Perkins Centre, University of Sydney, Level 2, Building D17, Sydney, Australia.
⁴ Sydney Medical School, University of Sydney, Sydney, Australia.
⁵ Cardiology Department, Concord Repatriation General Hospital, Sydney, Australia.
⁶ Heart Research Institute, Charles Perkins Centre, University of Sydney, Sydney Australia.

No abstract available

Comment on

Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination.
Kaasenbrood F, Hollander M, Rutten FH, Gerhards LJ, Hoes AW, Tieleman RG. Kaasenbrood F, et al. Europace. 2016 Oct;18(10):1514-1520. doi: 10.1093/europace/euv426. Epub 2016 Feb 6. Europace. 2016. PMID: 26851813 Free PMC article.